|Publication number||US6936072 B2|
|Application number||US 10/194,428|
|Publication date||Aug 30, 2005|
|Filing date||Jul 10, 2002|
|Priority date||Aug 18, 1999|
|Also published as||US20030125807, US20050206039|
|Publication number||10194428, 194428, US 6936072 B2, US 6936072B2, US-B2-6936072, US6936072 B2, US6936072B2|
|Inventors||Gregory Lambrecht, Sean Kavanaugh, Scott Stonebrook|
|Original Assignee||Intrinsic Therapeutics, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (85), Referenced by (100), Classifications (100), Legal Events (4)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a continuation-in-part of U.S. application Ser. No. 09/696,636 filed on Oct. 25, 2000 now U.S. Pat. No. 6,508,839 which is a continuation-in-part of U.S. application Ser. No. 09/642,450 filed on Aug. 18, 2000, now U.S. Pat. No. 6,482,235 which is a continuation-in-part of U.S. application Ser. No. 09/608,797 filed on Jun. 30, 2000, now U.S. Pat. No. 6,425,919 and claims benefit to U.S. Provisional Application No. 60/311,559 filed Aug. 10, 2001, U.S. Provisional Application No. 60/304,545 filed Jul. 10, 2001, U.S. Provisional Application No. 60/149,490 filed Aug. 18, 1999, U.S. Provisional Application No. 60/161,085 filed Oct. 25, 1999 and U.S. Provisional Application No. 60/172,996 filed Dec. 21, 1999, the entire teachings of these applications being incorporated herein by reference.
1. Field of the Invention
The present invention relates generally to intervertebral disc devices suitable for delivery into a body to treat injured discs or to improve the function of non-injured discs.
Methods of encapsulating a new intervertebral prosthesis are not known in the art. The most relevant prior art can be found in references concerning the encapsulation of stents and grafts in flexible biocompatible materials. However, these references are limited to teaching the coating of certain cylindrical structures with a single or double-sided coating of expanded polytetrafluoroethylene. These teachings do not address some or all of the requirements of a new intervertebral disc device which may be semicircular in cross-section, collapsible, fatigue resistant, biocompatible, and suitable for the dynamic disc environment.
Fluoropolymer tubings and other extruded or expanded polymer products are well known in the art and can provide an excellent material for encapsulation. Expanded polytetrafluoroethylene (ePTFE) is made by expanding polytetrafluoroethylene (PTFE) tubing or sheet material under controlled conditions during the manufacturing process. This process alters the physical properties of the material by creating microscopic pores in the structure of the material. The resulting material is imparted with unique physical properties that make it ideal for use in medical devices, electronic insulators, high performance filters, and a host of other applications. Material made from ePTFE differs from regular PTFE in that the material is microporous, soft, very flexible, has a lower dielectric constant, increased linear strength, and improved biocompatibility.
The structure of ePTFE is unique in that the material is made up of a number of solid nodes inter-connected by a matrix of thin fibrils. The gaps, or pores, between the fibrils are what allows the material to excel in applications requiring cellular ingrowth. ePTFE is also utilized for its endothelization and thrombogenic properties. Both ePTFE and PTFE resin have long been utilized for implantable medical devices due to their inertness and biocompatibility. The amount of expansion in ePTFE is usually referred to as internodal distance (IND). IND is a measure of the average distance between the material's nodes. ePTFE is commonly available from manufacturers in IND sizes ranging from 5μ to over 200μ. IND plays a role in the softness, flexibility, and degree of potential ingrowth that the material exhibits. Some commercial suppliers of ePTFE sinter the outside of the material after the expansion process in order to make it more durable and smooth.
Other useful PTFE based materials known in the art are PTFE resin aqueous dispersions or “aqueous PTFE” and heat shrinkable PTFE. Aqueous PTFE is commonly comprised of milky white dispersions of PTFE particles in water stabilized by wetting agents. Its composition is usually 30 to 60 percent PTFE particles and the remainder is comprised of water and a nonionic surfactant. Objects can be dip-coated with repeated passes into aqueous PTFE until the final desired thickness is obtained. The water can then be removed and the other ingredients deactivated. The melting temperature of these resins are around 325° Celsius. The dried resin particles can be coalesced by heat into a continuous coating or the substrate can remain coated, or impregnated, with unmelted particles. Both glass fabric and synthetic substrates can be processed.
Heat shrinkable PTFE tubing is well known in the art and provides a method for application of a tight, protective covering to items that will be subjected to the extremes of heat, corrosion, shock, moisture, and other critical environmental conditions. Shrinkable PTFE tubing requires around 340° Celsius to recover. Upon reaching approximately 330° the PTFE goes into the “gel” state (amorphous from crystalline). PTFE begins to shrink at 340° and completes its recovery during the cooling cycle.
This disclosure utilizes particular orthopedic references, nomenclature, and conventions. Accordingly, several background figures and descriptions are included to aid in the understanding of the environment under which specific embodiments of the invention may be used.
The invention relates generally to methods of manufacture of intervertebral disc devices suitable for delivery into a body to treat injured or poorly functioning discs or to reinforce healthily discs.
In one or more of the several embodiments, the present invention provides for an intervertebral disc prosthesis that is biocompatible, collapsible, concave shaped, and sized to fit within the area defined by the superior and inferior end plates and outermost lamella of the anulus fibrosus of a functional spinal unit.
It is further objective of one or more of several embodiments of this invention to provide a device useful in shielding the nerves of the anulus and spinal cord from pressure and or chemicals within the disc.
It is a further objective of one or more of various embodiments to provide a device that provides support to a weakened or healthy anulus in an intervertebral disc.
It is a further object in one or more of the several embodiments to provide a method for the manufacture of one or more of the several embodiments of the invention.
It is a further object to provide in one or more of the several embodiments an encapsulating covering that is permanently retained on an intervertebral barrier device and substantially isolates it from bodily tissue.
It is a further objective of one or more of various embodiments to provide a method of encapsulating an intervertebral prosthesis in a biocompatible material that does not interfere with the deformation and flexibility of the barrier frame.
It is another object of several embodiments of the invention to provide a method of making an intervertebral disc implant by providing a barrier frame having first and second sides, positioning a first membrane adjacent the first side and a second membrane adjacent the second side, applying force so that the first membrane contacts the second membrane at one or more points and heating the first and second membrane to form bonds at one or more of those points. The first membrane may be attached to the second membrane. In one embodiment, the first membrane and second membrane may be opposing sides of an envelope. In a preferred embodiment, the first and/or second membrane is an ePTFE membrane. In another embodiment, a portion of the membrane is positioned beyond the frame or its periphery.
It is yet another object of the current invention to provide a method for making an intervertebral prosthesis by placing a first encapsulating material over a mandrel, placing a device frame on the first encapsulating material, placing a second encapsulating material on top of the device frame, placing a mandrel cover on top of the second encapsulating material and applying force so that the edges of the first and second encapsulating material form contact points with each other around the device frame and heating the mandrel and/or cover until the first and second encapsulating material bond to each other at the contact points, thereby encapsulating the frame.
It is yet another object of the current invention to provide a method for making an intervertebral prosthesis by placing a first biocompatible encapsulating material over a heatable mold with a curved face, the material being sized to extend from about 0.1 mm to about 0.5 mm beyond the edges of a barrier frame. The barrier frame, which is dimensioned to span beyond the distance defined by the maximum distance between an inferior and superior endplate of a normal intervertebral disc and to extend circumferentially along the lateral and posterior surfaces of an anulus, the barrier having a semi-circular cross-section and comprised of nickel titanium alloy, is placed on the first encapsulating material. A second encapsulating material, designed to extend from about 0.1 mm to about 5 mm beyond the edges of the barrier frame, is placed on top of the device frame. A mold cover with a concave interior corresponding to face of the mold on top of the second encapsulating material is placed on top of the device frame. Force is then applied such that the edges of the first and second encapsulating material form one or more contact points with each other around the barrier frame. The base and/or the cover and/or the frame sandwiched between the first and the second encapsulating material is heated until the first and second encapsulating material bond to each other at said one or more contact points.
It is a further object of various embodiments of the present invention to provide a method for making an intervertebral prosthesis by placing a first biocompatible encapsulating material over a heatable mold with a curved face, where the curved face has a first axis and a second axis which are perpendicular to one another. The first axis is a longitudinal axis which has a first radius of curvature and the second axis is a transverse axis which has a second radius of curvature. The first radius of curvature has a range of about 0.1 cm to about 4 cm and the second radius of curvature has a range of about 2.0 cm to about 7.0 cm. Alternatively, the device can be ‘U’ shaped in the transverse orientation and preferably has lateral legs in the range of about 0.1 cm to about 2.0 cm that protrude perpendicularly through a gradual curve with an inner diameter in the range of about 0.2 cm to about 1.5 cm.
The foregoing and other objects, features and advantages of the invention will be apparent from the following more particular description of preferred embodiments of the invention as illustrated in the accompanying drawings in which like reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention.
The environment in which various embodiments of the present invention find greatest utility is within a human intervertebral disc that has a weakened or compromised anulus.
Intervertebral disc 315 is comprised of the outer anulus 310 which normally surrounds and constrains the nucleus 320 to be wholly within the borders of the intervertebral disc space. Axis M extends between the anterior (A) and posterior (P) of the functional spine unit. The vertebrae also include facet joints 360 and the superior 390 and inferior 390′ pedicle that form the neural foramen 395.
In several of embodiments herein, the present invention provides a device for sealing or reinforcing defects in tissue walls separating two anatomic regions of the body and to methods of making such device. Alternatively, one or more of the several embodiments of the device may be used to provide support to tissue walls that do not exhibit holes but are nonetheless weakened and can benefit from an implanted support structure. Also, prosthetic devices and method of their manufacture are disclosed which provide the closure or support of a defect in the anulus of the human intervertebral disc, preventing the egress of material from within the disc and/or distributing pressure within the disc space across an inner wall surface of the disc.
Closure of the defect and/or support of the weakened sector comprising the defect can be achieved by placing a membrane or barrier device on an interior aspect of the defect. In the case of the intervertebral disc, the device 120 is positioned either on the interior aspect of the anulus proximate to the nucleus or between layers of the AF. The device 120 may be inserted in the desired location after dissecting a space between the anulus and nucleus. Alternatively, a portion of the nucleus and/or anulus may be resected to create adequate space. Ideally, the device 120 is inserted through a defect in the anular surface or through a minimally invasive iatrogenic hole 300. Such a hole is shown in FIG. 1D.
The geometries of the support frame 53 shown in
This embodiment employs a multitude of fingers 162 to aid in holding the membrane against the superior and inferior vertebral endplates. The distance between the superior-most point of the superior finger and the inferior-most point on the inferior finger is the frame height 172. This height 172 is preferably greater than the disc height at the inner surface of the posterior anulus. The greater height 172 of the frame 53 allows the fingers 162 to deflect along the superior and inferior vertebral endplates, enhancing the seal of the device 120 against egress of material from within the disc 15.
The spacing between the fingers 162 along the frame length 170 can be tailored to provide a desired stiffness of the frame 53. Greater spacing between any two neighboring fingers 162 can further be employed to insure that the fingers 162 do not touch if the frame 53 is required to take a bend along its length. The central strut 164 can connect the fingers and dissecting ends and preferably lies along the inner surface of the anulus 10 when seated within the disc 15. Various embodiments may employ struts 164 of greater or lesser heights and thicknesses to vary the stiffness of the overall frame 53 along its length 170 and height 172.
In an alternative embodiment, the device can be ‘U’ shaped in the transverse orientation and preferably has lateral legs in the range of about 0.1 cm to about 2.0 cm, preferably in the range of about 0.5 cm to about 1.3 cm, that protrude perpendicularly through a gradual curve with an inner diameter in the range of about 0.2 cm to about 1.5 cm.
The encapsulating membrane or material 51 of the device 120 may be a relatively soft, smooth, and flexible biocompatible material so that the device 120 does not injure the intra anular walls or superior and inferior endplates. Bio-compatality and inertness are also important so that there is minimal physiological reaction to the device 120. The material(s) comprising the encapsulating material 51 can be impermeable to liquid transfer such that its surface does not permit travel of disc tissue through its surface and outside the disc. Accordingly, the preferred embodiment is made of ePTFE, which exhibits these properties. ePTFE is also strong and resilient enough to withstand the high pressure and dynamic environment found in the intervertebral disc and aids in the devices ability to seal defects and shield nerves in the anulus. Preferably, the internodal distance of the ePTFE, i.e., the average distance between the material's nodes, ranges from 0.μ to over 200μ. As will be further discussed, the encapsulating membrane 51 can filly or partially encapsulate the frame 53 or merely form a portion of a single side of the frame 53.
Though the preferred embodiment of the device 120 utilizes ePTFE for the encapsulating material 51 other suitable biocompatible materials may be used. For example, the membrane may alternatively comprise biologic materials such as keratin, collagen, bio-engineered anulus fibrosus, protein polymers or the like. Other suitable synthetic materials include polyamides, polyimides, silicones, polyurethane, natural rubber, latex and other fluoropolymers such as perfluoroalkoxy (PFAs) and fluorinated ethylene-propylene (FEP). These materials can be affixed to the barrier frame through compression molding, solvent bonding, injection molding, or through in situ polymerization.
In one embodiment of the invention, the encapsulating material or membrane 51 can be fixed to the frame 53 by sutures. The frame 53 may simply be encapsulated in ePTFE material by suturing two pieces of material around the periphery of the frame 53. Also, to minimize the amount of stitches, a single folded piece of material or a tube may be used. This method provides a very durable attachment between the two pieces of material and yet permits the device to flex evenly. Suturing the encapsulating material 51 to the frame 53 can also permit the frame 53 to move or flex relatively unimpeded by the encapsulating material 51. Suturing is also advantageous because it is strong, reliable, finely detailed, and will not harm the disc. In addition to suturing along the periphery of the frame 53, the fingers 162 and internal geometry of the frame may be secured to the encapsulating material by suturing.
Ultrasonic welding may also be used as above to bond the edges of the ePTFE to each other around the periphery of the barrier frame 53. Because of the intense heat delivered by this method, the mechanical properties of the ePTFE may be different at the weld. This can be reduced by selectively welding the encapsulating material at measured points spanning the periphery of the barrier frame including between the fingers 162 and between other voids in the geometry.
In a preferred method of manufacturing the device 120, the frame 53 is encapsulated in ePTFE by first making a sandwich-like arrangement 300 of the frame 53 and a first 54 and second encapsulating material 55. Each of the encapsulating material 54 and 55 is comprised of a thin sheet of ePTFE that is patterned to extend around from about 0.004 inches to about 0.25 inches beyond the periphery of the frame. The thickness of the ePTFE may be between about 0.001 inches to about 0.25 inches and preferably in the range of about 0.005 inches to about 0.025 inches. The IND of each encapsulating material may be in the range of about 5μ to about 200μ with the higher value being more suited to encouraging tissue ingrowth but exhibiting less strength. The IND of each encapsulating material may be different to effect different mechanical properties on either side of the device, mechanical bonding, and fixation. The ePTFE material should preferably be of an unprocessed extrudate variety that has not been subjected to further surface treatments such as sintering and exhibits uniform physical and chemical properties throughout.
Besides exhibiting superior elasticity, strength, and biocompatibility, the material chosen for the barrier frame 53 will preferably be able to withstand the temperatures and exposure times required to monolithically encapsultate it in the encapsulating material 51. In this preferred embodiment, a nickel titanium alloy is chosen.
This method can alternatively be practiced using a tube or folded sheet of ePTFE so that fewer edges need form a bond to effectively encapsulate the frame 53. Using a folded sheet encapsulating material 51 can also be used to create a partially covered frame 53. Alternatively, using a tube is particularly advantageous in forming the arrangement 300 since the step of applying the second encapsulating material 55 is not necessary. The frame 53 is simply inserted in the hollow encapsulating material 51 and then heated in the covered mandrel.
Another method of making the device 120 comprises the adhesion of the first encapsulating material 54 to the second encapsulating material 55 using aqueous PTFE. Here a sandwich of first encapsulating material/aqueous PTFE/barrier frame/aqueous PTFE/second encapsulating material is made and then heated to the melting point of the aqueous PTFE, around 325°, which is less than the sintering temperature of the encapsulating material. In this way, the water and wetting agents are burned off and the PTFE particles melt and mechanically bond to the surfaces of the first and second encapsulating material 51.
Aqueous PTFE or other adhesion material may be used to encapsulate the frame 53 within a tube, folded single sheet, or between two sheets of the encapsulating material 51. Also, selected portions of the encapsulating material 51 can be coated with the adhesion material depending on the degree and location of the bonding one desires. For example, a single sheet encapsulating material 51 on a either side of the frame 53 may be attached with the aqueous PTFE by depositing it along either or both sides of the frame 53 allowing it to contact the encapsulating material through and around the frame 53 and heating it until mechanical bonds form. Other adhesion material may also be used to bond, either chemically or mechanically, the encapsulating material 51 to itself or the frame 53. Examples of adhesion material include, but are not limited to, common medical adhesives like cyanoacrylate, light curing adhesives, urethane, epoxy, and silicone. Further examples include polyamides, polyimides, silicones, polyurethane, natural rubber, latex and other fluoropolymers such PFAs and FEPs.
Heat shrinking PTFE wrap or tubing around the barrier frame 53 is yet another way to provide a biocompatible and resilient encapsulation. PTFE begins to shrink around 340° Celsius and completes its recovery during the cooling cycle. In one method, the barrier frame 53 can be preheated to around 340° Celsius and a slightly larger tube may be placed over it whereupon the tube shrinks in place upon contact and when cooled provides a smooth coverage leaving only two small uncovered spots at the tails of the barrier 53. These uncovered spots do not affect the devices ability to retain intervertebral disc material, pressure, or height. Using the methods described above, these ends may also be sutured or welded. Alternatively, an assembly of the barrier frame 53 placed within a slightly larger tube may be positioned on a mandrel 310 with a hemi circular face and covered with a mandrel cover 320 and then heated to around 340° Celsius until the PTFE shrink fits around barrier frame 53.
As disclosed above, partial encapsulation or covering of the frame 53 may be accomplished with these methods. For example, an encapsulating material 51 comprised of ePTFE disposed around the fingers 162 and face of the device 120 but leaving the center of the frame 53 exposed may be advantageous for delivery and placement of the device. By leaving a portion of the frame 53 uncovered, a solid contact point is provided that can be used to couple the device 120 to a delivery instrument. Alternatively, the encapsulating material 51 can be designed to have a channel within itself or covering a channel in the frame 53 that accepts a guide or probe from the delivery instrument.
An alternative method is comprised of applying an extremely thin, highly expanded PTFE film around the frame 53. By wrapping the film transversely around the long axis of the frame radial strength can be added to the underlying longitudinal strength of the PTFE tube. The radially wrapped tube can then be placed on the mandrel face 310 and compressed and heated to 350-390° Celsius in conjunction with the mandrel cover. The heating process will allow the film to shrink and bond to the underlying PTFE substrate and encapsulating the frame 53. The additional film will provide radial strength and minimize any potential for protrusion of the frame through the PTFE. In addition, while the film wrapping is being performed a template can be placed on the convex side of the PTFE tube. Over-wrapping of this tube will allow for creation of a pocket on the convex side of the frame 53. This pocket in conjunction with the windows left in the tube covering would allow for attachment of a delivery instrument to the convex side of the frame. An important manufacturing consideration of this application method is the need for such high temperatures for sufficient bonding of the PTFE film and its deleterious effects on the underlying metallic substrate. Using an FEP/PTFE laminated film with corresponding lower bonding temperatures of 300-320° Celsius can reduce this effect.
Subsequent to the application of pressure to the first encapsulating material and/or semicircular frame and/or second encapsulating material assembly and sintering the same to mechanically bond the ePTFE, the mandrel cover is removed and the device is removed from the mandrel. In this state the device is now ready for implantation into an intervertebral disc. In use, the encapsulated barrier is folded or crimped via stress-induced martinsite or heat induced martinsite into a delivery cannula so that it may be inserted through a naturally occurring or minimally invasive iatrogenic hole. The unique structure and composition of the device allows it to endure a ninety-degree bend and be delivered parallel to the anular lamellae and in front of the anular defect.
While references are made to a semi-circular frame and matching mandrels, alternative cross sectional shapes of the frame of the present invention may be employed to achieve various stiffness or pressure response characteristics of the overall device. As an example, compound curves may be desirable to create multiple convexities and concavities in the frame. Alternatively, a single concavity with varying radii of curvature may be employed rather than the single radius of a semi-circle. Appropriately shaped mandrels may be used with any of these shapes to achieve the encapsulation methods described above.
Accordingly, utilizing the methods described herein will provide a biocompatible and durable implant. In a preferred embodiment, the implant is folded or crimped into a delivery cannula so that it may be inserted through a naturally occurring or minimally invasive iatrogenic hole. Among other features, the unique structure and composition of the device allows it to endure a ninety-degree bend and to be delivered parallel to the anular lamellae and in front of the anular defect.
While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3526567 *||Apr 19, 1967||Sep 1, 1970||Avant Corp||Laminated card envelope|
|US5100422||May 26, 1989||Mar 31, 1992||Impra, Inc.||Blood vessel patch|
|US5171280||Mar 21, 1991||Dec 15, 1992||Sulzer Brothers Limited||Intervertebral prosthesis|
|US5192326||Sep 9, 1991||Mar 9, 1993||Pfizer Hospital Products Group, Inc.||Hydrogel bead intervertebral disc nucleus|
|US5201729||Nov 30, 1990||Apr 13, 1993||Laserscope||Method for performing percutaneous diskectomy using a laser|
|US5239982||Nov 5, 1992||Aug 31, 1993||Baxter International Inc.||Catheter depth gauge and method of use|
|US5320644||Jul 30, 1992||Jun 14, 1994||Sulzer Brothers Limited||Intervertebral disk prosthesis|
|US5370697||Feb 19, 1993||Dec 6, 1994||Sulzer Medizinaltechnik Ag||Artificial intervertebral disk member|
|US5549679||Mar 1, 1995||Aug 27, 1996||Kuslich; Stephen D.||Expandable fabric implant for stabilizing the spinal motion segment|
|US5552100||May 2, 1995||Sep 3, 1996||Baxter International Inc.||Method for manufacturing porous fluoropolymer films|
|US5571189||May 20, 1994||Nov 5, 1996||Kuslich; Stephen D.||Expandable fabric implant for stabilizing the spinal motion segment|
|US5641373||Apr 17, 1995||Jun 24, 1997||Baxter International Inc.||Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft|
|US5645597||Dec 29, 1995||Jul 8, 1997||Krapiva; Pavel I.||Disc replacement method and apparatus|
|US5702454||May 29, 1996||Dec 30, 1997||Sulzer Orthopadie Ag||Process for implanting an invertebral prosthesis|
|US5743917||Aug 25, 1994||Apr 28, 1998||Saxon; Allen||Prosthesis for the repair of soft tissue defects|
|US5755797||Oct 2, 1996||May 26, 1998||Sulzer Medizinaltechnik Ag||Intervertebral prosthesis and a process for implanting such a prosthesis|
|US5785705||Oct 24, 1995||Jul 28, 1998||Oratec Interventions, Inc.||RF method for controlled depth ablation of soft tissue|
|US5800549||Apr 30, 1997||Sep 1, 1998||Howmedica Inc.||Method and apparatus for injecting an elastic spinal implant|
|US5823994||Mar 15, 1996||Oct 20, 1998||Oratec Interventions, Inc.||Method and apparatus for soft tissue fixation|
|US5843173||Apr 18, 1997||Dec 1, 1998||Baxter International Inc.||Radially-enlargeable PTFE tape-reinforced vascular grafts and their methods of manufacture|
|US5888220||Jan 23, 1996||Mar 30, 1999||Advanced Bio Surfaces, Inc.||Articulating joint repair|
|US5919235||Sep 30, 1996||Jul 6, 1999||Sulzer Orthopaedie Ag||Intervertebral prosthesis|
|US5928279||Jul 3, 1996||Jul 27, 1999||Baxter International Inc.||Stented, radially expandable, tubular PTFE grafts|
|US5954716||Feb 19, 1998||Sep 21, 1999||Oratec Interventions, Inc||Method for modifying the length of a ligament|
|US5961545||Jan 17, 1997||Oct 5, 1999||Meadox Medicals, Inc.||EPTFE graft-stent composite device|
|US5976192||Dec 10, 1996||Nov 2, 1999||Baxter International Inc.||Method of forming an externally supported tape reinforced vascular graft|
|US6001056||Nov 13, 1998||Dec 14, 1999||Baxter International Inc.||Smooth ventricular assist device conduit|
|US6007570||Jun 24, 1997||Dec 28, 1999||Oratec Interventions, Inc.||Apparatus with functional element for performing function upon intervertebral discs|
|US6019793||Oct 21, 1996||Feb 1, 2000||Synthes||Surgical prosthetic device|
|US6073051||Jun 24, 1997||Jun 6, 2000||Oratec Interventions, Inc.||Apparatus for treating intervertebal discs with electromagnetic energy|
|US6099791||Mar 8, 1996||Aug 8, 2000||Baxter International Inc.||Methods of manufacture of multiaxially oriented fluoropolymer films|
|US6102930||May 15, 1998||Aug 15, 2000||Simmons, Jr.; Edward D.||Volumetric measurement device and method in lateral recess and foraminal spinal stenosis|
|US6120539||May 1, 1997||Sep 19, 2000||C. R. Bard Inc.||Prosthetic repair fabric|
|US6124523||Mar 10, 1995||Sep 26, 2000||Impra, Inc.||Encapsulated stent|
|US6126682||Sep 15, 1998||Oct 3, 2000||Oratec Interventions, Inc.||Method for treating annular fissures in intervertebral discs|
|US6132465||Jun 4, 1998||Oct 17, 2000||Raymedica, Inc.||Tapered prosthetic spinal disc nucleus|
|US6140452||Nov 18, 1998||Oct 31, 2000||Advanced Bio Surfaces, Inc.||Biomaterial for in situ tissue repair|
|US6146380||Jan 9, 1998||Nov 14, 2000||Radionics, Inc.||Bent tip electrical surgical probe|
|US6203735||Feb 3, 1997||Mar 20, 2001||Impra, Inc.||Method of making expanded polytetrafluoroethylene products|
|US6214039||Aug 24, 1995||Apr 10, 2001||Impra, Inc., A Subsidiary Of C. R. Bard, Inc.||Covered endoluminal stent and method of assembly|
|US6224630||May 29, 1998||May 1, 2001||Advanced Bio Surfaces, Inc.||Implantable tissue repair device|
|US6245099||Sep 30, 1999||Jun 12, 2001||Impra, Inc.||Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device|
|US6245107||May 28, 1999||Jun 12, 2001||Bret A. Ferree||Methods and apparatus for treating disc herniation|
|US6264695||Sep 30, 1999||Jul 24, 2001||Replication Medical, Inc.||Spinal nucleus implant|
|US6267834||Dec 1, 1998||Jul 31, 2001||Edwards Lifesciences Corp.||Process of manufacturing a radially expandable PTFE tape-reinforced vascular graft|
|US6273912||Feb 28, 1996||Aug 14, 2001||Impra, Inc.||Flanged graft for end-to-side anastomosis|
|US6280475||Sep 2, 1999||Aug 28, 2001||Stryker Technologies Corporation||Hydrogel intervertebral disc nucleus implantation method|
|US6312462||Sep 22, 1999||Nov 6, 2001||Impra, Inc.||Prosthesis for abdominal aortic aneurysm repair|
|US6355063||Jan 20, 2000||Mar 12, 2002||Impra, Inc.||Expanded PTFE drug delivery graft|
|US6371990||Oct 16, 2000||Apr 16, 2002||Bret A. Ferree||Annulus fibrosis augmentation methods and apparatus|
|US6383214||Mar 21, 2000||May 7, 2002||Impra, Inc., A Subsidiary Of C. R. Bard, Inc.||Encapsulated stent|
|US6398803||Sep 2, 1999||Jun 4, 2002||Impra, Inc., A Subsidiary Of C.R. Bard, Inc.||Partial encapsulation of stents|
|US6416537||Jun 27, 2000||Jul 9, 2002||Atrium Medical Corporation||Multi-stage prosthesis|
|US6419704||Oct 8, 1999||Jul 16, 2002||Bret Ferree||Artificial intervertebral disc replacement methods and apparatus|
|US6428576||Apr 14, 2000||Aug 6, 2002||Endospine, Ltd.||System for repairing inter-vertebral discs|
|US6520967||May 15, 2000||Feb 18, 2003||Cauthen Research Group, Inc.||Spinal implant insertion instrument for spinal interbody prostheses|
|US6579291||Oct 10, 2000||Jun 17, 2003||Spinalabs, Llc||Devices and methods for the treatment of spinal disorders|
|US6726696 *||Jun 28, 2002||Apr 27, 2004||Advanced Catheter Engineering, Inc.||Patches and collars for medical applications and methods of use|
|US20020007218||Sep 5, 2001||Jan 17, 2002||Cauthen Joseph C.||Spinal disc annulus reconstruction method and spinal disc annulus stent|
|US20020077701||Dec 17, 2001||Jun 20, 2002||Kuslich Stephen D.||Annulus-reinforcing band|
|US20020111688||Mar 1, 2002||Aug 15, 2002||Cauthen Joseph C.||Intervertebral disc annulus stent|
|US20020120337||Apr 30, 2002||Aug 29, 2002||Cauthen Joseph C.||Intervertebral disc annulus repair device|
|US20020123807||Feb 15, 2002||Sep 5, 2002||Cauthen Joseph C.||Spinal disc annulus reconstruction method and spinal disc annulus stent|
|US20020147496||Apr 6, 2001||Oct 10, 2002||Integrated Vascular Systems, Inc.||Apparatus for treating spinal discs|
|US20020151980||Jun 11, 2002||Oct 17, 2002||Cauthen Joseph C.||Intervertebral disc annulus repair device|
|US20020165542||Apr 11, 2002||Nov 7, 2002||Ferree Bret A.||Annulus fibrosis augmentation methods and apparatus|
|US20020189622||Apr 29, 2002||Dec 19, 2002||Cauthen Joseph C.||Spinal disc annulus reconstruction method and spinal disc annulus stent|
|US20020198599||Jul 30, 2002||Dec 26, 2002||David Haldimann||System for repairing inter-vertebral discs|
|US20030004574||Aug 22, 2002||Jan 2, 2003||Ferree Bret A.||Disc and annulus augmentation using biologic tissue|
|US20030040796||Jun 26, 2002||Feb 27, 2003||Ferree Bret A.||Devices used to treat disc herniation and attachment mechanisms therefore|
|US20030074075||Aug 27, 2002||Apr 17, 2003||Thomas James C.||Expandable implant for partial disc replacement and reinforcement of a disc partially removed in a discectomy and for reduction and maintenance of alignment of cancellous bone fractures and methods and apparatuses for same|
|US20030074076||Nov 25, 2002||Apr 17, 2003||Ferree Bret A.||Artificial intervertebral disc replacements with endplates|
|US20030078579||Oct 3, 2002||Apr 24, 2003||Ferree Bret A.||Annular repair devices and methods|
|US20040002764||Apr 30, 2003||Jan 1, 2004||Raymedica, Inc.||Self-transitioning spinal disc anulus occlusion device and method of use|
|EP0700671A1||Sep 4, 1995||Mar 13, 1996||Howmedica Inc.||Hydrogel intervertebral disc nucleus|
|WO2000018328A1||Sep 30, 1999||Apr 6, 2000||Impra, Inc.||Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device|
|WO2000044288A1||Jan 27, 2000||Aug 3, 2000||Aesculap Ag & Co. Kg||Surgical instrument for inserting intervertebral implants|
|WO2000045741A1||Feb 2, 2000||Aug 10, 2000||Impra, Inc.||Partial encapsulation of stents|
|WO2001028468A1||Oct 20, 2000||Apr 26, 2001||Cauthen Research Group, Inc.||Spinal implant insertion instrument for spinal interbody prostheses|
|WO2001039696A1||Nov 10, 2000||Jun 7, 2001||Endologix, Inc.||Ptfe embedded low profile endoluminal prosthesis|
|WO2001045577A2||Dec 6, 2000||Jun 28, 2001||Sdgi Holdings, Inc.||Intervertebral disc treatment devices and methods|
|WO2001052914A1||Jan 18, 2001||Jul 26, 2001||Impra, Inc., A Subsidiary Of C.R. Bard, Inc.||Expanded ptfe drug delivery graft|
|WO2002051622A2||Dec 11, 2001||Jul 4, 2002||Scimed Life Systems, Inc.||Method of reducing the wall thickness of a ptfe tube and product formed thereby|
|WO2002058599A2||Oct 26, 2001||Aug 1, 2002||Sdgi Holdings, Inc.||Annulus repair systems and methods|
|WO2002067824A2||Feb 27, 2002||Sep 6, 2002||Sdgi Holdings, Inc.||Woven orthopedic implants|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7658765||Oct 22, 2004||Feb 9, 2010||Intrinsic Therapeutics, Inc.||Resilient intervertebral disc implant|
|US7670379||Feb 16, 2006||Mar 2, 2010||Anulex Technologies, Inc.||Spinal disc annulus reconstruction method|
|US7713303||Apr 28, 2005||May 11, 2010||Warsaw Orthopedic, Inc.||Collagen-based materials and methods for augmenting intervertebral discs|
|US7717961||Feb 5, 2003||May 18, 2010||Intrinsic Therapeutics, Inc.||Apparatus delivery in an intervertebral disc|
|US7727241||Jun 21, 2004||Jun 1, 2010||Intrinsic Therapeutics, Inc.||Device for delivering an implant through an annular defect in an intervertebral disc|
|US7731981||Jan 23, 2007||Jun 8, 2010||Warsaw Orthopedic, Inc.||Collagen-based materials and methods for treating synovial joints|
|US7744651||Jun 29, 2010||Warsaw Orthopedic, Inc||Compositions and methods for treating intervertebral discs with collagen-based materials|
|US7749273||Jul 6, 2010||Anulex Technologies, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US7749275||Jul 6, 2010||Intrinsic Therapeutics, Inc.||Method of reducing spinal implant migration|
|US7828850||Feb 10, 2006||Nov 9, 2010||Anulex Technologies, Inc.||Methods and devices for spinal disc annulus reconstruction and repair|
|US7857857||Nov 10, 2005||Dec 28, 2010||The Board Of Trustees Of The Leland Stanford Junior University||Devices, systems and methods for augmenting intervertebral discs|
|US7867278||Mar 14, 2008||Jan 11, 2011||Intrinsic Therapeutics, Inc.||Intervertebral disc anulus implant|
|US7879097||May 3, 2006||Feb 1, 2011||Intrinsic Therapeutics, Inc.||Method of performing a procedure within a disc|
|US7883527||Oct 31, 2007||Feb 8, 2011||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US7901430||Mar 8, 2011||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US7901455||Mar 8, 2011||Shriners Hospitals For Children||Tendon or ligament bioprostheses and methods of making same|
|US7909879||Nov 9, 2006||Mar 22, 2011||Anulex Technologies, Inc.||Intervertebral disc annulus stent|
|US7922768||Nov 14, 2006||Apr 12, 2011||Anulex Technologies, Inc.||Spinal disc annulus reconstruction method and deformable spinal disc annulus stent|
|US7931689||Apr 26, 2011||Spineology Inc.||Method and apparatus for treating a vertebral body|
|US7935147||Sep 26, 2005||May 3, 2011||Anulex Technologies, Inc.||Method and apparatus for enhanced delivery of treatment device to the intervertebral disc annulus|
|US7951201||Jan 12, 2007||May 31, 2011||Anulex Technologies, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US7959679||Jun 14, 2011||Intrinsic Therapeutics, Inc.||Intervertebral anulus and nucleus augmentation|
|US7963992||Jun 21, 2011||Anulex Technologies, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US7972337||Dec 19, 2006||Jul 5, 2011||Intrinsic Therapeutics, Inc.||Devices and methods for bone anchoring|
|US7985257||Nov 6, 2006||Jul 26, 2011||Anulex Technologies, Inc.||Methods and devices for spinal disc annulus reconstruction and repair|
|US7993405||Dec 8, 2006||Aug 9, 2011||Anulex Technologies, Inc.||Spinal disc annulus repair system and methods|
|US7998213||Nov 17, 2006||Aug 16, 2011||Intrinsic Therapeutics, Inc.||Intervertebral disc herniation repair|
|US8002836||Sep 20, 2004||Aug 23, 2011||Intrinsic Therapeutics, Inc.||Method for the treatment of the intervertebral disc anulus|
|US8021425||Sep 20, 2011||Intrinsic Therapeutics, Inc.||Versatile method of repairing an intervertebral disc|
|US8025698||Apr 27, 2009||Sep 27, 2011||Intrinsic Therapeutics, Inc.||Method of rehabilitating an anulus fibrosus|
|US8034112||Oct 11, 2011||Anulex Technologies, Inc.||Spinal disc annulus reconstruction method and spinal disc annulus stent|
|US8048160||Dec 22, 2005||Nov 1, 2011||Anulex Technologies, Inc.||Intervertebral disc annulus stent|
|US8088165||Mar 23, 2006||Jan 3, 2012||Anulex Technologies, Inc.||Spinal disc annulus reconstruction method and deformable spinal disc annulus stent|
|US8105382||Jan 31, 2012||Interventional Spine, Inc.||Intervertebral implant|
|US8114082||Aug 20, 2009||Feb 14, 2012||Intrinsic Therapeutics, Inc.||Anchoring system for disc repair|
|US8118779||Jun 30, 2006||Feb 21, 2012||Warsaw Orthopedic, Inc.||Collagen delivery device|
|US8128698||Oct 14, 2008||Mar 6, 2012||Anulex Technologies, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US8163022||Apr 24, 2012||Anulex Technologies, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US8177813 *||Sep 20, 2008||May 15, 2012||Life Spine, Inc.||Expandable spinal spacer|
|US8177839||May 15, 2012||Shriners Hospitals For Children||Woven and/or braided fiber implants and methods of making same|
|US8231678||May 3, 2006||Jul 31, 2012||Intrinsic Therapeutics, Inc.||Method of treating a herniated disc|
|US8257437||Sep 4, 2012||Intrinsic Therapeutics, Inc.||Methods of intervertebral disc augmentation|
|US8323341||Nov 12, 2009||Dec 4, 2012||Intrinsic Therapeutics, Inc.||Impaction grafting for vertebral fusion|
|US8361155||Jan 29, 2013||Intrinsic Therapeutics, Inc.||Soft tissue impaction methods|
|US8367148||Oct 9, 2009||Feb 5, 2013||Mimedx Group, Inc.||Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches|
|US8394146||Mar 12, 2013||Intrinsic Therapeutics, Inc.||Vertebral anchoring methods|
|US8399619||Jun 30, 2006||Mar 19, 2013||Warsaw Orthopedic, Inc.||Injectable collagen material|
|US8409284||Apr 2, 2013||Intrinsic Therapeutics, Inc.||Methods of repairing herniated segments in the disc|
|US8454612||Aug 20, 2009||Jun 4, 2013||Intrinsic Therapeutics, Inc.||Method for vertebral endplate reconstruction|
|US8454697||Apr 5, 2012||Jun 4, 2013||Anulex Technologies, Inc.||Method and apparatus for the treatment of tissue|
|US8460319||Jun 11, 2013||Anulex Technologies, Inc.||Intervertebral disc annulus repair system and method|
|US8556977||Nov 12, 2010||Oct 15, 2013||Anulex Technologies, Inc.||Tissue anchoring system and method|
|US8568481||Dec 22, 2011||Oct 29, 2013||Interventional Spine, Inc.||Intervertebral implant|
|US8632590||Sep 26, 2006||Jan 21, 2014||Anulex Technologies, Inc.||Apparatus and methods for the treatment of the intervertebral disc|
|US8652153||Aug 10, 2010||Feb 18, 2014||Anulex Technologies, Inc.||Intervertebral disc annulus repair system and bone anchor delivery tool|
|US8858633 *||Feb 20, 2008||Oct 14, 2014||Shriners Hospital For Children||In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers|
|US8986378||Nov 2, 2012||Mar 24, 2015||Mimedx Group, Inc.||Implantable collagen devices and related methods and systems of making same|
|US9039741||Mar 7, 2013||May 26, 2015||Intrinsic Therapeutics, Inc.||Bone anchor systems|
|US9050194||May 5, 2010||Jun 9, 2015||Stryker Spine||Expandable spinal implant apparatus and method of use|
|US9078775||Oct 9, 2009||Jul 14, 2015||Mimedx Group, Inc.||Methods of making collagen fiber medical constructs and related medical constructs, including nerve guides and patches|
|US9095442||Jan 23, 2012||Aug 4, 2015||Krt Investors, Inc.||Method and apparatus for the treatment of the intervertebral disc annulus|
|US9114025||Jun 29, 2011||Aug 25, 2015||Krt Investors, Inc.||Methods and devices for spinal disc annulus reconstruction and repair|
|US9125759||Dec 28, 2012||Sep 8, 2015||Mimedx Group, Inc.||Biocomposite medical constructs including artificial tissues, vessels and patches|
|US9179976||Jun 6, 2011||Nov 10, 2015||Mimedx Group, Inc.||Methods of making collagen fiber medical constructs and related medical constructs, including tubes|
|US9192372||Jun 3, 2013||Nov 24, 2015||Krt Investors, Inc.||Method for the treatment of tissue|
|US9216077||May 13, 2009||Dec 22, 2015||Mimedx Group, Inc.||Medical constructs of twisted lengths of collagen fibers and methods of making same|
|US9226832||Jan 28, 2013||Jan 5, 2016||Intrinsic Therapeutics, Inc.||Interbody fusion material retention methods|
|US9277903||Oct 31, 2007||Mar 8, 2016||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US9333087||Dec 22, 2014||May 10, 2016||Intrinsic Therapeutics, Inc.||Herniated disc repair|
|US9393105||Sep 9, 2014||Jul 19, 2016||Shriners Hospitals For Children||In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers|
|US9433404||Oct 31, 2013||Sep 6, 2016||Suture Concepts Inc.||Method and apparatus for closing fissures in the annulus fibrosus|
|US9451997 *||Mar 18, 2015||Sep 27, 2016||K2M, Inc.||Facet device and method|
|US20050155612 *||Mar 11, 2005||Jul 21, 2005||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US20060247776 *||May 2, 2005||Nov 2, 2006||The Board Of Trustees Of The Leland Stanford Junior University||Systems and methods for augmenting intervertebral discs|
|US20060247784 *||Nov 10, 2005||Nov 2, 2006||Kim Daniel H||Devices, systems and methods for augmenting intervertebral discs|
|US20060276901 *||Jun 3, 2005||Dec 7, 2006||Zipnick Richard I||Minimally invasive apparatus to manipulate and revitalize spinal column disc|
|US20070093874 *||Oct 25, 2005||Apr 26, 2007||Raul Chirife||System and method of AV interval selection in an implantable medical device|
|US20070118222 *||Nov 21, 2006||May 24, 2007||Vertegen, Inc.||Intervertebral devices and methods|
|US20070134343 *||Jan 23, 2007||Jun 14, 2007||Trieu Hai H||Collagen-based materials and methods for treating synovial joints|
|US20070233252 *||Feb 23, 2007||Oct 4, 2007||Kim Daniel H||Devices, systems and methods for treating intervertebral discs|
|US20080004703 *||Jun 30, 2006||Jan 3, 2008||Warsaw Orthopedic, Inc.||Method of treating a patient using a collagen material|
|US20080071301 *||Oct 31, 2007||Mar 20, 2008||Nuvasive, Inc.||Annulotomy closure device and related methods|
|US20080132899 *||May 17, 2005||Jun 5, 2008||Shadduck John H||Composite implant and method for treating bone abnormalities|
|US20080140108 *||Oct 31, 2007||Jun 12, 2008||Nuvasive, Inc||Annulotomy closure device and related methods|
|US20080140207 *||Dec 7, 2007||Jun 12, 2008||Interventional Spine, Inc.||Intervertebral implant|
|US20080161917 *||Dec 27, 2007||Jul 3, 2008||Shriners Hospitals For Children||Methods of making high-strength ndga polymerized collagen fibers and related collagen-prep methods, medical devices and constructs|
|US20080188933 *||Dec 27, 2007||Aug 7, 2008||Shriners Hospitals For Children||Woven and/or braided fiber implants and methods of making same|
|US20080200992 *||Feb 20, 2008||Aug 21, 2008||Shriners Hospitals For Children||In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers|
|US20080215150 *||Dec 27, 2007||Sep 4, 2008||Shriners Hospitals For Children||Tendon or ligament bioprostheses and methods of making same|
|US20090082808 *||Sep 20, 2008||Mar 26, 2009||Butler Michael S||Expandable Spinal Spacer|
|US20090216233 *||Feb 20, 2009||Aug 27, 2009||Mimedx, Inc.||Biostaples suitable for wrist, hand and other ligament replacements or repairs|
|US20090222099 *||Feb 28, 2008||Sep 3, 2009||Warsaw Orthopedics, Inc.||Self Centering Nucleus Implant|
|US20090287308 *||May 13, 2009||Nov 19, 2009||Tian Davis||Medical constructs of twisted lengths of collagen fibers and methods of making same|
|US20090292361 *||May 21, 2009||Nov 26, 2009||Rudolf Morgenstern Lopez||Intervertebral implant and installation tool|
|US20100094318 *||Oct 9, 2009||Apr 15, 2010||Mengyan Li||Methods of making collagen fiber medical constructs and related medical constructs, including nerve guides and patches|
|US20100094404 *||Oct 9, 2009||Apr 15, 2010||Kerriann Greenhalgh||Methods of Making Biocomposite Medical Constructs and Related Constructs Including Artificial Tissues, Vessels and Patches|
|US20100286779 *||Nov 11, 2010||Thibodeau Lee L||Expandable spinal implant apparatus and method of use|
|US20110130838 *||May 21, 2009||Jun 2, 2011||Interventional Spine, Inc.||Intervertebral implant and installation tool|
|US20150190181 *||Mar 18, 2015||Jul 9, 2015||K Spine, Inc.||Facet device and method|
|WO2007062080A2 *||Nov 20, 2006||May 31, 2007||Philipp Lang||Intervetebral devices and methods|
|U.S. Classification||623/17.16, 623/17.11|
|International Classification||A61F2/44, A61F2/28, A61B5/107, A61F2/30, B29C31/00, A61F2/46, A61B17/00, A61F2/02, A61F2/00, A61B17/32, A61B19/00, A61B17/70, A61B17/22, A61B17/34|
|Cooperative Classification||A61F2002/30971, A61F2002/30092, A61F2/4611, A61F2002/30909, A61F2/30723, A61F2002/30075, A61F2210/0014, A61F2002/448, A61F2002/4658, A61F2/30907, A61F2002/30228, A61F2002/30589, A61F2002/302, A61F2/2846, A61F2220/0075, A61F2230/0082, A61B2090/061, A61B5/1076, A61F2210/0061, A61F2002/30566, A61B2017/3445, A61F2230/0065, A61F2002/30136, A61F2002/4662, A61F2002/30289, A61F2002/4627, A61F2310/00029, A61F2/4657, A61B17/320708, A61F2002/30291, A61F2/442, A61F2002/4635, A61F2002/4661, A61F2230/0091, A61F2002/30172, A61F2002/30261, A61F2002/30062, A61F2002/30131, A61F2002/30583, A61F2310/00365, A61F2310/00023, A61F2210/0004, A61F2230/0034, A61F2002/444, A61F2310/00976, A61F2/4601, A61B2017/00261, A61B2090/062, A61F2002/30177, A61B2017/22077, A61F2002/30166, A61F2002/30777, A61F2230/0004, A61F2/441, A61F2310/00017, A61F2230/0028, A61F2002/30601, A61F2230/0056, A61F2002/30014, A61F2310/0097, A61F2002/4435, A61F2002/30462, A61F2002/30677, A61F2002/30187, A61F2230/0069, A61F2250/0018, A61F2230/0052, A61F2002/30224, A61F2002/30571, A61B2017/320044, A61F2002/30576, A61F2002/30785, A61F2310/00293, A61F2002/2817, A61B5/4514, A61F2310/00161, A61F2230/0013, A61F2210/0085|
|European Classification||A61B5/107J, A61F2/44D, A61F2/44B, A61F2/46M, A61F2/46B7, A61B17/3207C|
|Feb 28, 2005||AS||Assignment|
Owner name: INTRINSIC THERAPEUTICS, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:INTRINSIC ORTHOPEDICS, INC.;REEL/FRAME:016308/0816
Effective date: 20021220
|Jul 27, 2005||AS||Assignment|
Owner name: INTRINSIC THERAPEUTICS, INC., MASSACHUSETTS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LAMBRECHT, GREGORY;KAVANAUGH, SEAN;STONEBROOK, SCOTT;REEL/FRAME:016838/0493;SIGNING DATES FROM 20050616 TO 20050708
|Feb 23, 2009||FPAY||Fee payment|
Year of fee payment: 4
|Feb 28, 2013||FPAY||Fee payment|
Year of fee payment: 8